Exploiting O-GlcNAc dyshomeostasis to screen O-GlcNAc transferase intellectual disability variants

Huijie Yuan1, Conor W Mitchell2, Andrew T Ferenbach3

  • 1Section for Neurobiology, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark; Danish Research Institute of Translational Neuroscience DANDRITE-Nordic EMBL Partnership for Molecular Medicine, Aarhus University, Aarhus, Denmark; Division of Molecular, Cell and Developmental Biology, School of Life Sciences, University of Dundee, Dundee, UK.

Stem Cell Reports
|December 20, 2024
PubMed
Summary

Researchers developed a new method to identify disease-causing O-GlcNAc transferase (OGT) variants in OGT congenital disorder of glycosylation (OGT-CDG). This approach helps predict variant pathogenicity and reveals reduced O-GlcNAc homeostasis disruption as a common OGT-CDG mechanism.